Article Information
vol. 7 no. 3
Published By
Online ISSN
History
- Received September 2, 2020
- Accepted April 19, 2021
- Published online July 19, 2021.
Article Versions
- previous version (May 21, 2021 - 02:16).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Jan C. Thomassen1,2⇑,
- Tobias Trojan1,
- Maxine Walz1,
- Christina Vohlen2,3,
- Gregor Fink2,
- Ernst Rietschel1,
- Miguel A. Alejandre Alcazar1,2,3 and
- Silke van Koningsbruggen-Rietschel1
- 1CF Center, Children's Hospital, Faculty of Medicine, University of Cologne, Cologne, Germany
- 2Translational Experimental Pediatrics – Experimental Pulmonology, Children's Hospital, Faculty of Medicine, University of Cologne, Cologne, Germany
- 3Center of Molecular Medicine Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany
- Corresponding author: Jan C. Thomassen (Jan.thomassen{at}uk-koeln.de)
Article usage
Altmetrics
Vol 7 Issue 3
Table of Contents
Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β1 are linked to inflammatory response in sputum of cystic fibrosis patients with Pseudomonas aeruginosa
